Sensus Healthcare Announces Low 3% Keloid Recurrence in Multicenter Case Series of 297 Patients Treated with Superficial Radiation Therapy SRT-100, a Low-energy X-ray Technology, Used at Site of Keloidectomy Treatment
A non-surgical treatment option that delivers remarkable cure rates while preserving healthy tissue. The innovative SRT-100 Vision™ delivers 95 plus percent cure rates while eliminating aspects of treatment that often cause anxiety, slow healing and recovery, and leave patients with embarrassing scarring. The SRT-100 Vision™ has been cleared by the U.S. Food and Drug Administration for the treatment of non-melanoma skin cancer and keloids.
The treatment is painless and is typically given 3 days a week for a total of 20 treatments. Your initial visit is reserved for simulation and treatment planning, and will last about 45 minutes. After that your treatment visits with only take about 15 minutes.
Other than mild irritation at the treatment site, your body is unaffected, and you can resume your normal activities without restrictions.
Patients that would benefit from SRT include those with the following conditions:
- Poor wound healing
- Skin atrophy
- History of MRSA infection
- Diabetes
- Immunosuppression
- Peripheral vascular disease
- Lower extremity edema
- Those on anticoagulant therapy
- Multiple tumors requiring treatment
- Inability to perform necessary post-operative care
SCC Before, During, And After SRT
A NOTABLY AFFECTIVE TREATMENT FOR KELOIDS
SRT for keloids is given immediately following excision, and is typically administered in 3 treatment sessions.
Call today to schedule a superficial radiation therapy consultation
